Role of cyclin kinase inhibitor p21 in systemic autoimmunity

Journal of Immunology

Volumn 167, Issue 7, 2001, Pages 4067-4074

  Santiago Raber, M L ^a   Lawson, B R ^a   Dummer, W ^a   Barnhouse, M ^a   Koundouris, S ^a   Wilson, C B ^a   Kono, D H ^a   Theofilopoulos, A N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21;

ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; GENE DELETION; HEMATOPOIETIC STEM CELL; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; MOUSE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; STEM CELL; SYSTEMIC DISEASE;

EID: 0035478717     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.7.4067     Document Type: Article

References (41)

1. 1-phase progression
2. Cancer cell cycles
3. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
4. p21 is a universal inhibitor of cyclin kinases
5. p21-negative regulator of the cell cycle
6. An overview of the cell cycle arrest protein, p21 (WAF1)
7. p21 (WAF1/Cip1): More than a break to the cell cycle?
8. P53: Death star
9. C1P1/WAF1
10. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
11. Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence
12. Replicative senescence: An old lives' tale?
13. IFN-γ induction of p21 (WAF1) is required for cell cycle inhibition and suppression of apoptosis
14. Inhibition of the interferon-γ/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21 WAF1 promoter region
15. 1 checkpoint control
16. Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion
17. The genes of systemic autoimmunity
18. Why do defects in the Fas-Fas ligand system cause autoimmunity?
19. Apoptosis in rheumatic diseases
20. 4+ cells of older lupus mice
21. Maturational changes in CD4 cell subsets and lymphokine production in BXSB mice
22. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development
23. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
24. Determination of lymphocyte division by flow cytometry
25. fyn in their activation and expansion
26. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery
27. Superantigens and their potential role in human disease
28. Treatment of murine lupus with cDNA encoding IFN-γR/Fc
29. Homeostatic T cell proliferation: How far can T cells be activated to self-ligands?
30. Selecting and maintaining a diverse T-cell repertoire
31. + T cells
32. 1 sensitizes primary cultured non-transformed T cells to TCR-mediated apoptosis
33. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle
34. Cutting edge: Apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo
35. Homozygous C1q deficiency caused glomerulonephritis associated with multiple apoptotic bodies
36. Serum amyloid P component controls chromalin degradation and prevents antinuclear autoimmunity
37. WAF1/C1P-1/SD11 in kidney tubule cells affects the course of cisplatin-induced acute renal failure
38. C1p1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis
39. WAF1/C1P1 gene ameliorates progression to chronic renal failure
40. WAF1/C1P1 is required for glomerular hypertrophy in experimental diabetic nephropathy
41. Kip1 safeguards against inflammatory injury